Evidence map›Paper›PMID 29126977›Full record

ArticleCellular signalling2018

Enhancement of inosine-mediated A

Ajith A Welihinda, Manmeet Kaur, Kaviya S Raveendran, Edward P Amento

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Colorectal cancer: the facts in the case of the microbiota.The Journal of clinical investigation · 2022
    Review
  13. Allosteric Modulation of Adenosine AInternational journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  18. Article
  19. Review
  20. Inosine: a novel treatment for sciatic nerve injury.Neural regeneration research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ajith A WelihindaMolecular Medicine Research Institute, 428 Oakmead Parkway, Sunnyvale, CA 94085. Electronic address: awelihinda@mmrx.org.
Manmeet KaurMolecular Medicine Research Institute, 428 Oakmead Parkway, Sunnyvale, CA 94085.
Kaviya S RaveendranMolecular Medicine Research Institute, 428 Oakmead Parkway, Sunnyvale, CA 94085.
Edward P AmentoMolecular Medicine Research Institute, 428 Oakmead Parkway, Sunnyvale, CA 94085.
Molecular Medicine Research Institute · US

Funding

Positive allosteric modulation of the A2aR for treatment of acute inflammationR21AI105518 · NIAID · MOLECULAR MEDICINE RESEARCH INSTITUTE · PI AMENTO, EDWARD P · 2014 to 2015
$536k
NIAID NIH HHS R21 AI105518
6 · The paper itself

Abstract

Inosine is an endogenous nucleoside that is produced by metabolic deamination of adenosine. Inosine is metabolically more stable (half-life 15h) than adenosine (half-life <10s). Inosine exerts anti-inflammatory and immunomodulatory effects similar to those observed with adenosine. These effects are mediated in part through the adenosine A

Indexed as

Signal TransductionAllosteric RegulationAnimalsCell MembraneChemokine CCL3Chemokine CCL4CHO CellsCricetulusCyclic AMPGene Expression RegulationHEK293 CellsHumansInosineLipopolysaccharidesMiceMice, Inbred BALB CChemokine CCL3Chemokine CCL4Cyclic AMPInosineLipopolysaccharidesMAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Receptor, Adenosine A2AThioinosineTumor Necrosis Factor-alphaA(2A)RcAMPCytokinesERK1/2InosinePAM

Identifiers

PMID29126977
PMCPMC5732040
OpenAlexW2767465106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.